Despite strong biological rationale for the use of type-I IFNs for the treatment of acute myeloid leukemia (AML), their usage is limited to few hematologic malignancies. Here, we propose that innate immune sensing machinery, particularly the stimulator of IFN genes pathway, may be exploited to deliver antileukemic effects in AML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/1541-7786.MCR-20-0871 | DOI Listing |
Publication Analysis
Top Keywords
treatment acute
8
acute myeloid
8
myeloid leukemia
8
dog trick
4
trick type
4
type ifn-based
4
ifn-based treatment
4
leukemia despite
4
despite strong
4
strong biological
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!